TNRC6C and prostate carcinoma: STK4 is the key kinase participated in the Hippo signalling pathway.22 A study has showed that the protein level of STK4 decreases in the progression of prostate cancer.23 Based on RIP assay in this study, the expression of STK4 was regulated by lncRNA TNRC6C‐AS1.